ICU Medical's Q1 Adjusted Earnings, Revenue Decline-March 2024-www.financetom.com

ICU Medical's Q1 Adjusted Earnings, Revenue Decline

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

ICU Medical's Q1 Adjusted Earnings, Revenue Decline

May 8, 2024 3:59 AM

06:27 AM EDT, 05/08/2024 (MT Newswires) -- ICU Medical ( ICUI ) reported Q1 adjusted earnings Tuesday of $0.96 per diluted share, down from $1.74 a year earlier.

Four analysts polled by Capital IQ expected $0.85.

Revenue for the quarter ended March 31 was $566.7 million, compared with $568.6 million a year earlier.

Three analysts polled by Capital IQ expected $554 million.

Previous page： Pernod Ricard annual sales hit by U.S. and Chinese woes Next page： Phibro Animal Health Stock Surges 18% After-Hours On Strong Q4 Earnings Beat

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Pernod Ricard annual sales hit by U.S. and Chinese woes

Aug 27, 2025

PARIS (Reuters) -Pernod Ricard reported a 3% fall in full-year 2025 organic sales on Thursday, in line with forecasts, amid tariff uncertainty and sliding sales in the United States and China. The French company, which is the world's second-biggest Western spirits maker by revenue after Diageo, said its 2026 fiscal year would be one of transition, with improving sales trends...

Phibro Animal Health Stock Surges 18% After-Hours On Strong Q4 Earnings Beat

Aug 27, 2025

Phibro Animal Health Corporation ( PAHC ) shares jumped 17.98% to $37.99 in after-hours trading on Thursday, following strong fourth-quarter results that beat expectations. Check out the current price of PAHC stock here. Q4 Results Exceed Forecasts The global animal health company reported fourth-quarter net sales of $378.7 million, up 39% year-over-year. Net income surged to $17.2 million from $0.8...

Why Telomir Pharmaceuticals Stock Ran Up 35% On Wednesday Night

Aug 27, 2025

Telomir Pharmaceuticals Inc. ( TELO ) shares surged 35.14% in after-hours trading to $2.00 on Wednesday, following the company’s announcement of promising in vitro data for its lead drug candidate Telomir-1. Check out the current price of TELO stock here. The Miami-based preclinical biotechnology company shared new research results that position Telomir-1 as a potential first-in-class epigenetic therapy for cancer,...

American Bitcoin, backed by Trump's sons, aims to start trading in September

Aug 27, 2025

HONG KONG, Aug 28 (Reuters) - American Bitcoin, the bitcoin miner backed by U.S. President Donald Trump's two sons, has locked in crypto and traditional investors to back an all-stock merger that will allow the firm to soon start trading on the Nasdaq, the company's largest investor said. The unlisted firm's merger with Gryphon Digital Mining ( GRYP ) is...